Skip to main content
Extendicare Inc. (EXETF)
OTCMKTS · Delayed Price · Currency is USD
10.27
+0.05 (0.49%)
May 9, 2025, 1:52 PM EDT

Extendicare Revenue

Extendicare had revenue of 374.65M CAD in the quarter ending March 31, 2025, with 2.06% growth. This brings the company's revenue in the last twelve months to 1.47B, up 9.38% year-over-year. In the year 2024, Extendicare had annual revenue of 1.47B with 12.36% growth.

Revenue (ttm)
1.47B CAD
Revenue Growth
+9.38%
P/S Ratio
0.84
Revenue / Employee
62.71K CAD
Employees
23,500
Market Cap
858.03M USD

Revenue Chart

* This company reports financials in CAD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20241.47B161.25M12.36%
Dec 31, 20231.30B83.38M6.83%
Dec 31, 20221.22B54.59M4.68%
Dec 31, 20211.17B63.44M5.75%
Dec 31, 20201.10B-28.41M-2.51%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo Inc. 1.73B
Veradigm 588.02M
Tian'an Technology Group 1.78M
Glass House Brands 200.90M
Elite Pharmaceuticals 70.00M
Northwest Biotherapeutics 1.38M
BioStem Technologies 301.83M
American Oncology Network 1.76B
Revenue Rankings

Extendicare News

More News